CH628876A5 - Verfahren zur herstellung neuer alkylolamide jodierbarer aminosaeuren und deren verwendung. - Google Patents

Verfahren zur herstellung neuer alkylolamide jodierbarer aminosaeuren und deren verwendung. Download PDF

Info

Publication number
CH628876A5
CH628876A5 CH451577A CH451577A CH628876A5 CH 628876 A5 CH628876 A5 CH 628876A5 CH 451577 A CH451577 A CH 451577A CH 451577 A CH451577 A CH 451577A CH 628876 A5 CH628876 A5 CH 628876A5
Authority
CH
Switzerland
Prior art keywords
carbon atoms
group
preparation
alkylolamides
amino acid
Prior art date
Application number
CH451577A
Other languages
German (de)
English (en)
Inventor
Hans-Georg Dr Batz
Klaus Dr Stellner
Hans-Ralf Dr Linke
Guenter Dr Weimann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of CH628876A5 publication Critical patent/CH628876A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CH451577A 1976-04-15 1977-04-12 Verfahren zur herstellung neuer alkylolamide jodierbarer aminosaeuren und deren verwendung. CH628876A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762659837 DE2659837A1 (de) 1976-04-15 1976-04-15 Alkylolamide jodierbarer aminosaeuren, ein verfahren zu ihrer herstellung und deren verwendung
DE2616724A DE2616724C3 (de) 1976-04-15 1976-04-15 Hydroxylalkylamide von Hydroxyphenylalaninen, ein Verfahren zu ihrer Herstellung und deren Verwendung

Publications (1)

Publication Number Publication Date
CH628876A5 true CH628876A5 (de) 1982-03-31

Family

ID=25770350

Family Applications (1)

Application Number Title Priority Date Filing Date
CH451577A CH628876A5 (de) 1976-04-15 1977-04-12 Verfahren zur herstellung neuer alkylolamide jodierbarer aminosaeuren und deren verwendung.

Country Status (9)

Country Link
US (1) US4202873A (enExample)
JP (1) JPS52128349A (enExample)
AT (1) AT348988B (enExample)
BE (1) BE853257A (enExample)
CH (1) CH628876A5 (enExample)
DE (2) DE2616724C3 (enExample)
FR (1) FR2348191A1 (enExample)
GB (1) GB1523845A (enExample)
NL (1) NL7701293A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654451B1 (en) * 1993-01-14 2000-02-22 Magainin Pharma Amino acids and peptides having modified c-terminals and modified n-terminals
BRPI0608330A2 (pt) 2005-05-05 2009-12-29 Acergy France Sa rebocamento e instalação submarina de artigos compridos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3189646A (en) * 1962-04-26 1965-06-15 Coastal Interchemical Company Process for the preparation of n-methylol amide derivatives
US3763234A (en) * 1970-12-03 1973-10-02 Halcon International Inc Preparation of amides
US3714249A (en) * 1971-01-22 1973-01-30 Sun Oil Co Hydroxyalkylaminoalkylamides and their preparation

Also Published As

Publication number Publication date
US4202873A (en) 1980-05-13
FR2348191B1 (enExample) 1980-02-15
FR2348191A1 (fr) 1977-11-10
AT348988B (de) 1979-03-12
BE853257A (fr) 1977-10-05
DE2659837A1 (de) 1977-10-20
ATA172377A (de) 1978-08-15
GB1523845A (en) 1978-09-06
DE2616724A1 (de) 1977-10-20
DE2616724B2 (de) 1979-02-15
JPS52128349A (en) 1977-10-27
NL7701293A (nl) 1977-10-18
DE2616724C3 (de) 1979-10-04
JPS5715102B2 (enExample) 1982-03-29

Similar Documents

Publication Publication Date Title
EP0371262B1 (de) Neue Digoxigenin-Derivate und ihre Verwendung
EP0417725B1 (de) Gallensäurederivate, Verfahren zu ihrer Herstellung, Verwendung als Arzneimittel
DE3788961T2 (de) Verfahren zur herstellung von polysubstituierten diethylentriaminpentaessigsäuren.
DE19630102A1 (de) Neue aktivierte Amphetamine
WO1990015798A1 (de) Aminoalkylmaleimide und davon abgeleitete hapten- und antigenderivate sowie konjugate mit peptiden oder proteinen
EP0060999B1 (de) Galactopyranoside Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Antigene oder Immunadsorbentien
DE2724762C3 (de) Cortisolderivate und radioimmunoilogisches Verfahrens
DE3025226C2 (de) Pterinderivate und ihre Verwendung zur radioimmunologischen Bestimmung von Pterinen
EP0442372B1 (de) Verbesserte markierte Haptene, Verfahren zu deren Herstellung sowie Verwendung dieser markierten Haptene in Immunoassays
DE2914842A1 (de) Reagenzien zur verwendung bei bindungsproben beim nachweis von diphenylhydantoin
EP0692979A1 (de) Bifunktionelle chelatbildner und ihre anwendung in der radiopharmazeutik
DE60013818T2 (de) Quaternäre ammoniumverbindungen, verfahren zu deren herstellung und deren pharmazeutische verwendung
CH628876A5 (de) Verfahren zur herstellung neuer alkylolamide jodierbarer aminosaeuren und deren verwendung.
EP0599325B1 (de) Verbesserte B12-Konjugate
DE2818644C2 (de) Mit radioaktivem Jod markierte 3'-Brom-thyrocarbonsäurederivate und Verfahren zu deren Herstellung
AT356824B (de) Verfahren zur herstellung von jodierbaren bindungsanalogstoffen fuer radioimmunologische versuche
EP0501250A1 (de) Fucose-markierte Batracylinderivate
DE2537129A1 (de) Reaktive unsymmetrische dicarbonsaeureester
DE69326321T2 (de) Neues aminosäurederivat
EP0089693B1 (de) Steroidester von N-(2-Halogenethyl)-N-nitroso-carbamoyl-aminosäuren und deren Peptiden, sowie Verfahren zu deren Herstellung
EP0207415B1 (de) Verbrückungsreagenz, Verfahren zu seiner Herstellung und seine Anwendung
DE2902292A1 (de) Verfahren zur herstellung von 4-aminobuttersaeure und deren derivaten
WO1995012610A1 (de) N-alkyl-peptidchelatbildner, deren metallkomplexe mit radionukliden, verfahren zu ihrer herstellung und diese verbindungen enthaltende radiopharmazeutische zusammensetzungen
DE2354253C2 (de) Verfahren zur Herstellung eines Reagens zur radioimmunologischen Bestimmung von Testosteron
AT396474B (de) Neue d-glucosamin-derivate

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased